Cargando…

Acute and subacute toxicity studies of a poly herbal formulation used for diabetes

OBJECTIVES: PHF-dia (Poly Herbal Formulation Diabetes) is a polyhedral formulation possessing antihyperglycemic and antihyperlipdimic effects. This study aims to assess acute and sub-acute toxicity of PHF-dia in rats. METHODS: This is an experimental study conducted in two different phases. Acute to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghauri, Aymen Owais, Mohiuddin, Ejaz, Rehman, Tayyeba, Siddiqui, Hk. Sheraz Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378416/
https://www.ncbi.nlm.nih.gov/pubmed/35991237
http://dx.doi.org/10.12669/pjms.38.6.5928
_version_ 1784768552153120768
author Ghauri, Aymen Owais
Mohiuddin, Ejaz
Rehman, Tayyeba
Siddiqui, Hk. Sheraz Muhammad
author_facet Ghauri, Aymen Owais
Mohiuddin, Ejaz
Rehman, Tayyeba
Siddiqui, Hk. Sheraz Muhammad
author_sort Ghauri, Aymen Owais
collection PubMed
description OBJECTIVES: PHF-dia (Poly Herbal Formulation Diabetes) is a polyhedral formulation possessing antihyperglycemic and antihyperlipdimic effects. This study aims to assess acute and sub-acute toxicity of PHF-dia in rats. METHODS: This is an experimental study conducted in two different phases. Acute toxicity was conducted for 14 days and sub-acute toxicity was conducted for 28 days. Both studies were conducted in animal house of Jinnah University for Women, Karachi, Pakistan. Acute toxicity was evaluated in vivo with single time oral administration of 400 mg/kg and 2000 mg/kg doses for two weeks. Sub-acute toxicity was investigated with the application of repeated doses of 150 mg/kg/day, 250 mg/kg/day and 500 mg/kg/day for 28 days. RESULTS: Acute toxicity study results showed no toxic symptoms, behavioral changes or death in rats up to 2000 mg/kg. Therefore, LD(50) of oral toxic dose must be more than 2000 mg/ml. Similarly, sub-acute toxicity studies confirmed the safety of PHF-dia and showed no clinical symptoms nor biochemical or histological variation in rats treated with 150 mg/kg, 250 mg/kg and 500 mg/kg compared to the control group (p <0.05). CONCLUSION: This indicates safe nature of PHF-dia for the further clinical trials. However, mechanism of action of PHF-dia is not fully understood.
format Online
Article
Text
id pubmed-9378416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-93784162022-08-19 Acute and subacute toxicity studies of a poly herbal formulation used for diabetes Ghauri, Aymen Owais Mohiuddin, Ejaz Rehman, Tayyeba Siddiqui, Hk. Sheraz Muhammad Pak J Med Sci Original Article OBJECTIVES: PHF-dia (Poly Herbal Formulation Diabetes) is a polyhedral formulation possessing antihyperglycemic and antihyperlipdimic effects. This study aims to assess acute and sub-acute toxicity of PHF-dia in rats. METHODS: This is an experimental study conducted in two different phases. Acute toxicity was conducted for 14 days and sub-acute toxicity was conducted for 28 days. Both studies were conducted in animal house of Jinnah University for Women, Karachi, Pakistan. Acute toxicity was evaluated in vivo with single time oral administration of 400 mg/kg and 2000 mg/kg doses for two weeks. Sub-acute toxicity was investigated with the application of repeated doses of 150 mg/kg/day, 250 mg/kg/day and 500 mg/kg/day for 28 days. RESULTS: Acute toxicity study results showed no toxic symptoms, behavioral changes or death in rats up to 2000 mg/kg. Therefore, LD(50) of oral toxic dose must be more than 2000 mg/ml. Similarly, sub-acute toxicity studies confirmed the safety of PHF-dia and showed no clinical symptoms nor biochemical or histological variation in rats treated with 150 mg/kg, 250 mg/kg and 500 mg/kg compared to the control group (p <0.05). CONCLUSION: This indicates safe nature of PHF-dia for the further clinical trials. However, mechanism of action of PHF-dia is not fully understood. Professional Medical Publications 2022 /pmc/articles/PMC9378416/ /pubmed/35991237 http://dx.doi.org/10.12669/pjms.38.6.5928 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ghauri, Aymen Owais
Mohiuddin, Ejaz
Rehman, Tayyeba
Siddiqui, Hk. Sheraz Muhammad
Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title_full Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title_fullStr Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title_full_unstemmed Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title_short Acute and subacute toxicity studies of a poly herbal formulation used for diabetes
title_sort acute and subacute toxicity studies of a poly herbal formulation used for diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378416/
https://www.ncbi.nlm.nih.gov/pubmed/35991237
http://dx.doi.org/10.12669/pjms.38.6.5928
work_keys_str_mv AT ghauriaymenowais acuteandsubacutetoxicitystudiesofapolyherbalformulationusedfordiabetes
AT mohiuddinejaz acuteandsubacutetoxicitystudiesofapolyherbalformulationusedfordiabetes
AT rehmantayyeba acuteandsubacutetoxicitystudiesofapolyherbalformulationusedfordiabetes
AT siddiquihksherazmuhammad acuteandsubacutetoxicitystudiesofapolyherbalformulationusedfordiabetes